Treatment of rheumatoid arthritis with biological agents-as a typical and common immune-mediated inflammatory disease

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Molecules involved in the disease process facilitated our understanding of pathogenesis of the disease with unknown etiology such as immune-mediated and inflammatory diseases. Moreover, the targeted therapies against the proposed molecular targets by biological agents provide enormous benefits to the patients and societies. Here, I will review recent progress of the biological treatment in the immune-inflammatory diseases by focusing on the rheumatoid arthritis, the disease characterized by persistent polyarthritis leading to joint destruction and disability with autoimmune features, as a role model.

Original languageEnglish
Pages (from-to)600-608
Number of pages9
JournalProceedings of the Japan Academy Series B: Physical and Biological Sciences
Volume93
Issue number8
DOIs
Publication statusPublished - 2017

Fingerprint

arthritis
biological treatment
rheumatoid arthritis
Biological Factors
etiology
Rheumatoid Arthritis
pathogenesis
therapeutics
Immune System Diseases
disabilities
Therapeutics
Arthritis
Joints
destruction
therapy
molecules

Keywords

  • Biologics
  • Cytokines
  • Immune-mediated inflammatory diseases
  • Rheumatoid arthritis
  • Therapy

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Physics and Astronomy(all)

Cite this

@article{da4398c07d2e431389039e03d8f838cd,
title = "Treatment of rheumatoid arthritis with biological agents-as a typical and common immune-mediated inflammatory disease",
abstract = "Molecules involved in the disease process facilitated our understanding of pathogenesis of the disease with unknown etiology such as immune-mediated and inflammatory diseases. Moreover, the targeted therapies against the proposed molecular targets by biological agents provide enormous benefits to the patients and societies. Here, I will review recent progress of the biological treatment in the immune-inflammatory diseases by focusing on the rheumatoid arthritis, the disease characterized by persistent polyarthritis leading to joint destruction and disability with autoimmune features, as a role model.",
keywords = "Biologics, Cytokines, Immune-mediated inflammatory diseases, Rheumatoid arthritis, Therapy",
author = "Tsutomu Takeuchi",
year = "2017",
doi = "10.2183/pjab.93.038",
language = "English",
volume = "93",
pages = "600--608",
journal = "Proceedings of the Japan Academy Series B: Physical and Biological Sciences",
issn = "0386-2208",
publisher = "Japan Academy",
number = "8",

}

TY - JOUR

T1 - Treatment of rheumatoid arthritis with biological agents-as a typical and common immune-mediated inflammatory disease

AU - Takeuchi, Tsutomu

PY - 2017

Y1 - 2017

N2 - Molecules involved in the disease process facilitated our understanding of pathogenesis of the disease with unknown etiology such as immune-mediated and inflammatory diseases. Moreover, the targeted therapies against the proposed molecular targets by biological agents provide enormous benefits to the patients and societies. Here, I will review recent progress of the biological treatment in the immune-inflammatory diseases by focusing on the rheumatoid arthritis, the disease characterized by persistent polyarthritis leading to joint destruction and disability with autoimmune features, as a role model.

AB - Molecules involved in the disease process facilitated our understanding of pathogenesis of the disease with unknown etiology such as immune-mediated and inflammatory diseases. Moreover, the targeted therapies against the proposed molecular targets by biological agents provide enormous benefits to the patients and societies. Here, I will review recent progress of the biological treatment in the immune-inflammatory diseases by focusing on the rheumatoid arthritis, the disease characterized by persistent polyarthritis leading to joint destruction and disability with autoimmune features, as a role model.

KW - Biologics

KW - Cytokines

KW - Immune-mediated inflammatory diseases

KW - Rheumatoid arthritis

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=85030974204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030974204&partnerID=8YFLogxK

U2 - 10.2183/pjab.93.038

DO - 10.2183/pjab.93.038

M3 - Review article

VL - 93

SP - 600

EP - 608

JO - Proceedings of the Japan Academy Series B: Physical and Biological Sciences

JF - Proceedings of the Japan Academy Series B: Physical and Biological Sciences

SN - 0386-2208

IS - 8

ER -